The relationship between the concentrations of cortisol and T 4 with outcome in the preterm infants has not been well studied.
INTRODUCTION
Hypofunctioning of the cortisol and/or thyroid hormone systems may contribute to the poor outcome of the preterm infant. Most investigations that have suggested a role for the endocrine systems in the outcome of the preterm infant have examined a single hormone system. [1] [2] [3] [4] [5] [6] [7] [8] [9] These studies primarily have addressed the role of glucocorticoid hormones, [1] [2] [3] [4] [5] both for prevention of neonatal lung disease as well as treatment of catecholamineunresponsive hypotension. 10, 11 Results in the latter group suggested that cortisol may be important for the resolution of acute illness in the preterm infant as it is in the adult. 12, 13 The vast majority of reported studies used pharmacological doses of dexamethasone for the prevention of chronic lung disease. It is now clear after more than 15 years of this therapy that there are multiple adverse outcomes being reported [14] [15] [16] and a call to halt and re-evaluate this therapy is now at hand. [17] [18] [19] A re-emergence of studies into the role of thyroid hormone in the outcome of the preterm infant have begun to take center stage.
Earlier studies failed to demonstrate a consistent positive effect from thyroid hormone therapy. 20, 21 Current studies have suggested that abnormalities in thyroid function may play a role in the neurological outcome of the preterm infant. [6] [7] [8] [9] Van Wassenaer et al. found similar free T 4 values for sick and well preterm infants, 22 while the nadir for total thyroid hormone values during week 1 was lower for ill infants and the youngest gestational age infants. Replacement studies designed to address poor outcome [23] [24] [25] have not demonstrated clear efficacy from treatment of low T 4 values. 8,26 -28 Dynamic testing of both cortisol and thyroid systems in the preterm infants demonstrates that the end organs are able to respond to stimulated release of hormone. Thus, any dysfunction is likely due to central abnormalities consistent with developmental and thus transient hypopituitarism. Treatment of central hypothyroidism increases the metabolism of cortisol to biologically inactive cortisone 29 and would lead to an increased likelihood of cortisol crisis if there is concomitant hypocortisolism. Therefore, unopposed thyroid hormone therapy may worsen the outcome of preterm infants with unsuspected hypothalamic-pituitary-adrenal axis dysfunction on immaturity. Studying these two systems together may lead to improved understanding of the role of endocrine systems in the outcome of the preterm infants. This report was designed to examine retrospectively the interaction of these systems in the acute and long-term outcome of preterm infants in a single newborn intensive care unit within a larger study, whose purpose was to define the role of cortisol in short-and long-term physiological stability.
METHODS

Subjects
Infants less than 37 weeks gestational age admitted to the newborn intensive care unit at the Children's Hospital of New Mexico were eligible for the study. Infants were enrolled after the nature of the protocol was fully explained and informed consent was obtained from the parents using an institutional review board-approved consent. A subset of this group of infants has been included in previous publications of the relationship of cortisol concentrations with early neonatal illness and pulmonary outcome. 30, 31 Early illness was measured using a pulmonary measure of respiratory support, the respiratory acuity score (RAS) that measures maximum respiratory support. 32 RAS is the sum of the whole numbers for oxygen concentrations greater than 25% (to correct for altitude), positive end expiratory pressure (cm H 2 O), peak inspiratory pressure (cm H 2 O), and mechanical breaths/ minute (For example, a patient on 50% O 2 , 21/4 pressures, and intermittent mandatory ventilation rate of 30 would have a RAS of 80). Resolution of pulmonary disease has been the marker of glucocorticoid efficacy and is associated with long-term survival.
In order to define the resolution of pulmonary disease during week 1 of postnatal life, three RAS groups were prospectively defined: RAS-Mild Group included infants who had a RAS value less than 80 on days 2 and 6; RAS-Moderate Group consisted of infants who had a RAS value greater than 80 on day 2 and less than 80 by day 6 and RAS-Severe Group included infants with a RAS value greater than 80 on both days. RAS groups were previously defined using results from Watterberg et al., 32 which demonstrated that RAS values correlated well with blood gas data. RAS groups were prospectively defined so as to reflect the expected pattern of respiratory support during week 1 of postnatal life. Three discrete and exclusive gestational age groups were used: (1) 23 to 27 weeks, (2) 28 to 31 weeks, and (3) 32 to 36 weeks. Gestational age groups were developed previously. 30 The relationship between cortisol and gestational age was significant using gestational age as a continuous variable. The analysis was cumbersome with the number of cells required, so the data were reviewed for likely statistical breakpoints as well as clinical judgment for groupings.
Samples
Blood was collected on postnatal days 2, 4, and 6 for the measurement of cortisol concentrations. Cortisol values were measured using the Diagnostic Corporation Kit (Los Angeles, CA) with duplicate samples. The intra-assay and the interassay variabilities for the assay were 5.6% and 7.5%, respectively. Crossreaction for all naturally occurring adrenal steroids was less than 0.1%. Cortisol values were converted from mg/dl to nmol/l by multiplying a factor of 27.6 and expressed in log cortisol for continuous statistical analysis. Mean cortisol values were used to create groups such that group 1r5 mg/dl (138 nmol/l) and group 2Z5 mg/dl. The lower cortisol group (group 1) was chosen because of the association of cortisol values less than 5 mg/dl during illness to high mortality in adults. 33 Thyroxine values were measured as part of the state newbornscreening program in New Mexico within the first 5 days of postnatal life and none of the infants had primary hypothyroidism. Thyroxine values (T 4 ) were separated into two groups: Group 1<4 mg/dl and group 2Z4 mg/dl; values less than 4 mg/dl during illness are associated with a poor outcome in the adult population. 34 Statistics All data were analyzed using the SAS Version 6 (SAS Institute, Inc., Cary, NC) statistical package. The evaluation began with a model of T 4 values on gestational age with RAS group as a cofactor. Cortisol concentration was added to the analysis as the final factor in the analysis of each dependent variable.
Analysis of variance and repeated measures analysis of variance statistics were used for evaluation of continuous variables in order to model the relationships between cortisol, T 4 , gestational age, and illness for Figures 1 and 2. Pearson's w 2 test was used for comparison of proportions using a cutoff value (Table 2) .
RESULTS
In all, 210 infants (of the available 284 infants enrolled in study from 1992-1995) had matched cortisol and T 4 values and were included in the analysis (gestational age group 1 ¼ 46, 2 ¼ 110, 3 ¼ 54). There were 90 girls and 120 boys. The distribution of infants by clinical acuity was RAS-Mild ¼ 90 infants, RASModerate ¼ 73, and RAS-Severe ¼ 47 infants. The distribution of outcomes of infants by clinical acuity group is displayed in Table 1 . 
The RAS-Severe Group has a poorer outcome with 26% mortality and 66% BPD at 36 weeks corrected gestational age compared to 9.5% mortality/55% BPD in the RAS-Moderate Group and 6% mortality/27% BPD in the RAS-Mild Group. Cortisol values <5 mg/ dl were found in 39% of the total population, while T 4 concentrations were <4 mg/dl in 25% of infants and 55% of all infants had a T 4 greater than 7 mg/dl. The relationship of first cortisol values (carried out at p2 days of age) with week 1 mean cortisol values was examined in order to define the feasibility of using single cortisol values as a screen for mean cortisol values in the setting of low T 4 . A total of 50% of first values were in the same cortisol group as mean values. In all, 25% of the values were either over-or underestimated mean cortisol values, respectively.
Relationship of cortisol and thyroid hormone values with gestational age and illness Cortisol concentrations were inversely related to gestational age and severity of respiratory illness (p ¼ 0.012) such that cortisol values were the highest in the youngest gestational age infants and in those infants with the lowest requirements for pulmonary support during week 1. The overall model had a direct relationship with gestational age (p ¼ 0.0030; Figure 1) . Thyroid values increased with gestational age in the two sickest groups, while thyroid values were unaffected by gestational age in the group of infants with the mildest illness.
The overall model displayed in Figure 2 was significantly related to illness (p<0.01) such that as illness worsened (from Low, Moderate, and finally to Severe illness groups), average cortisol values sequentially decreased. For infants in the lower thyroid group, this relationship was not significantly different between groups. For the higher thyroid group, both the sicker groups had average cortisol values significantly lower than values in the infants with the mildest illness (p<0.05).
Relationship of cortisol and thyroid hormone with mortality The distribution of mean cortisol and T 4 values during week 1 demonstrated that 20/210 (9.5%) infants in the total group had combined low cortisol and thyroid hormone concentrations. Seven of the combined low cortisol/low thyroid hormone concentrations were in the youngest gestational age group (7/46), while 13/164 infants older than 27 weeks gestational age had combined low cortisol/thyroid hormone concentrations.
The physiological importance of these combined values is dependent on their co existence in ill infants and their relationship with outcome. The RAS-Severe Group had 12 deaths, 31 infants who were on oxygen at 36 weeks corrected gestational age and only four infants on room air. One infant on room air had a low T 4 and none of the room air infants had low cortisol values, but the small number of infants who were on room air at 36 weeks corrected did not allow for comparisons for all three groups. The survivors were combined for study. Thus, results were examined separately for the sickest infants (RAS Severe Group ¼ 47 infants; 22% of the total population). This group had high morbidity; 55% (11/20) of the infants with combined low hormonal values were from RAS group III. There was a preponderance of morbidity (combined low cortisol/thyroid hormone values) and mortality in the subset of RAS Severe group and the youngest age group. There were 16 infants in this group. In all, 10 of the 12 deaths for RAS Severe group and the four infants who had combined low values and died were within the youngest age group infants.
Displayed in Table 2 is the relationship of low cortisol, low T 4 , and low combined values with mortality at 36 weeks corrected gestational age. There was no significant difference in the distribution of low T 4 values (p ¼ 0.67). There was a trend to a difference for the distribution of low cortisol values with 8/12 deaths having cortisol values less than 5 mg/dl while 12/35 infants who lived had low cortisol values (p ¼ 0.08). Different cortisol and T 4 cut-values were then used to explore the possibility of a significant cut-point in the data. There was no T 4 value that resulted in a significant difference for those who survived versus those who died. In contrast, using a cortisol <7 mg/dl, all infants who died had mean cortisol less than this value, while 15/35 infants who lived had cortisol values lower than 7 mg/dl (p<0.005). In order to address the issue of a combined effect of thyroid hormone and cortisol concentrations on mortality, we studied groups who had both values below the cutoff value versus all others. This comparison resulted in a significant effect (Pearson's w 2 the p ¼ 0.045; using Fisher's exact test, p ¼ 0.051). Owing to of the very divergent statistical effects of cortisol and thyroid hormone when studied alone, it is likely that the combined effect reflects the dominant effect of cortisol rather than a true effect of both hormones.
SIGNIFICANCE
This is the first study to examine the combined relationship of thyroid hormone and cortisol concentrations to illness and outcome in the preterm infant population. We found that T 4 concentrations increased and cortisol values decreased with advancing gestational age, while the concentrations of both hormones were lower in infants with the highest respiratory support requirements across week 1. Finally, 11/20 combined low T 4 /cortisol values were found in the sickest group of infants (RAS Severe, 22% of total population and 48% of the deaths). Mortality correlated with lower cortisol values but not with lower T 4 values. These results are consistent with the coexistence of lower T 4 and cortisol values in early illness while suggesting a role for only cortisol in survival.
The physiological significance of low cortisol and thyroid hormones concentrations during illness in the preterm infant must be delineated before the values described here are "treated.'' Cortisol is necessary for survival during illness and thus, lower cortisol values in a setting of physiological instability and lack of improvement in ventilatory needs over week 1 would be consistent with the anticipated role for cortisol. Cortisol values are expected to increase during significant stress, and mortality is higher in ill adults who have low baseline and stimulated cortisol values (12, 13, and 35) . In the preterm infant population, general agreement about the physiological significance of lower values is not yet available. [36] [37] [38] [39] [40] [41] Most studies have not consistently correlated cortisol concentrations to physiological markers of cortisol effect before statistically examining the role of cortisol in outcomes. Our results have correlated cortisol values to both early severe and unresolved illness and to mortality.
In contrast to the known role for cortisol during illness, most studies suggest that thyroid hormone values normally decrease during illness, potentially to minimize the catabolic effects of illness. 42 Thyroxine values less than 4 mg/dl correlate to poor outcome serving as a marker of illness but are not felt to be causally related. Unless T 4 values are associated with a TSH greater than 20 mU/l, therapy is not recommended. 34 In the preterm infant, interpretation of low T 4 values is complicated by illness and developmental changes. [43] [44] [45] [46] Thyroid Binding Globulin (TBG) concentrations are developmentally low 22 and in the setting of euthyroid sick syndrome where factors such as TNF a interfere with the binding of T 4 to TBG resulting in a lower total T 4 that does not reflect appropriately the normal free T 4 values. 47 In addition, immaturity of the HPT axis may result in low T 4 values that would not be associated with an increase in TSH because of the presence of transient hypopituitarism. Our results are consistent with low T 4 values during illness but not a role in outcome.
Our results suggest that clinical trials using T 4 values for an entry criterion should address the issue of potentially coexistent low cortisol values. Our results show combined low T 4 /cortisol values in the youngest infants. These are the infants who are most likely to be placed in T 4 studies and therefore a deleterious outcome may occur from the use of thyroid hormone alone in the setting of combined hormone deficiencies. 29, 42 In summary, lower cortisol values correlated to increased mortality, while low T 4 values did not, suggesting that low cortisol rather than low thyroid hormone values may be an etiologic factor in increased neonatal mortality. The combination of lower cortisol and T 4 concentrations was more frequently found in infants who failed to improve their respiratory requirements in comparison to infants who improved or were on low settings across week 1. In addition, combined low values were found in the group most likely to be included in clinical trials. The immaturity of two endocrine systems in the transition of the preterm infant is consistent with central endocrine dysfunction (developmental hypopituitarism?) in preterm infants who are very ill during week 1. As cortisol crisis can be precipitated in the setting of combined cortisol/thyroid hormone deficiencies, endocrinologists have long started glucocorticoid hormone therapy concomitantly or prior to the use of thyroid hormones. We caution the use of thyroid hormone therapy in the ill preterm infant and encourage examination of the relationship of cortisol and thyroid hormone in prospective studies.
